X4 Pharmaceuticals (XFOR) Other Working Capital Changes (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Other Working Capital Changes of -$3.4 million for Q4 2025, down 704.28% on a QoQ basis from -$421000.0 in Q3 2025, and down 758.75% year-over-year from $514000.0 in Q4 2024.
X4 Pharmaceuticals (XFOR) Other Working Capital Changes (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Other Working Capital Changes history runs 1 years deep, the most recent figure standing at -$296000.0 for Q4 2025.
- Quarterly Other Working Capital Changes fell 758.75% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.2 million (down 521.96% YoY) and the FY2025 annual result came in at -$4.2 million, down 521.96% from the prior year.
- Other Working Capital Changes was -$3.4 million for Q4 2025 at X4 Pharmaceuticals, down from -$421000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.8 million in Q4 2023 and bottomed at -$3.4 million in Q4 2025.
- A 5-year average of -$59800.0 and a median of $110500.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 905.0% — and 2025, when it plunged 758.75%.
- X4 Pharmaceuticals' Other Working Capital Changes stood at $1.7 million in 2021, then tumbled by 55.89% to $768000.0 in 2022, then surged by 138.15% to $1.8 million in 2023, then slumped by 71.9% to $514000.0 in 2024, then plunged by 758.75% to -$3.4 million in 2025.
- Business Quant data shows XFOR's Other Working Capital Changes at -$296000.0 in Q4 2025, -$200000.0 in Q3 2025, and -$229000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 167.39 Mn | -49.65 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -421,000.00 |
| Sep 30, 2025 | -421,000.00 |
| Sep 30, 2025 | -421,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Jun 30, 2025 | -240,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Mar 31, 2025 | -201,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | -336,000.00 |
| Jun 30, 2024 | -336,000.00 |